VGLL1 抗体 (Cy3)
Quick Overview for VGLL1 抗体 (Cy3) (ABIN1419179)
抗原
See all VGLL1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
交叉反应
- 人
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human VGLL1
-
亚型
- IgG
-
-
-
-
应用备注
- IF(IHC-P) 1:50-200
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- VGLL1 (Vestigial Like 1 (VGLL1))
-
别名
- VGLL1
-
背景
-
Synonyms: TDU, VGL1, VGL 1, VGL-1, TONDU, Transcription cofactor vestigial like protein 1, Vestigial like 1, VGLL1_HUMAN.
Background: VGLL1 is a specific coactivator for the mammalian TEFs. The mammalian TEF and the Drosophila scalloped genes belong to a conserved family of transcriptional factors that possesses a TEA/ATTS DNA binding domain.
-
基因ID
- 51442
抗原
-